Method of evaluating autoimmune disease risk and treatment selection

    公开(公告)号:US12224070B2

    公开(公告)日:2025-02-11

    申请号:US17596015

    申请日:2020-06-02

    Abstract: Methods enabling prediction, screening, early diagnosis, and recommended intervention or treatment selection of autoimmune conditions using artificial intelligence operating in conjunction with large medical datasets. Logic is applied to historic population data to extract medical features and identify subjects with diagnosed autoimmune conditions, and the pre-diagnosis medical data is used to train a diagnosis classification algorithm. A self-supervised learning mechanism is separately used to generate a feature embedding transformation of the patients medical history into representational feature vectors. These patient feature vectors together with their expected diagnoses are used to train a multi-label classifier model using supervised learning. The embedding transformation and the multi-label classifier are then applied to a current subjects data to generate a patient diagnosis probability vector, predicting the existence of autoimmune conditions. These methods are applied to diagnose gastrointestinal autoimmune disorders using celiac disease as example.

    METHOD AND SYSTEM FOR CHARACTERIZING KERATINOUS FIBERS, IN PARTICULAR HUMAN EYELASHES

    公开(公告)号:US20250040873A1

    公开(公告)日:2025-02-06

    申请号:US18708979

    申请日:2022-10-21

    Applicant: L'Oreal

    Abstract: The present invention relates to a method for characterizing eyelashes or eyebrows which is implemented by computer and comprises the following steps, which are directed toward:—receiving data corresponding to a set of pixels in a close-up image of a body area comprising a plurality of eyelashes, preferably the entirety of a row of eyelashes or of an eyebrow, to be characterized:—applying at least one step of computer vision so as to obtain, on the basis of the image data received, a numerical evaluation of at least one characteristic numerical parameter from among, notably, the number of fibers, an average length of the fibers, an average thickness of the fibers, and a curvature of the fibers.

    METHODS, DEVICES AND SYSTEMS FOR MEDICAL CODE EVENT INFORMATION TRACKING

    公开(公告)号:US20250022587A1

    公开(公告)日:2025-01-16

    申请号:US18760443

    申请日:2024-07-01

    Applicant: Brooke Johns

    Inventor: Brooke Johns

    Abstract: A device is configured to process medical-event related information, such as associated with a medical code event, such as by receiving medical-event related information, recording medical event information with timestamps, generating additional medical information, displaying medical events and additional medical information on media display, visual indicators, and user devices to provide real-time notifications of recorded and reminders for upcoming medical events, and sending medical events with timestamps and additional medical information to other devices for further processing. The device may be configured as a code clock which includes an analog clock.

    Systems and methods for selecting a treatment schema based on user willingness

    公开(公告)号:US12198808B2

    公开(公告)日:2025-01-14

    申请号:US16589031

    申请日:2019-09-30

    Inventor: Kenneth Neumann

    Abstract: A system for selecting a treatment schema based on user willingness includes at least a first computing device configured to receive at least a user constitutional datum and at least a user ailment state from at least a second computing device. At least a first computing device is configured to determine, with an adaptive machine learning module, at least a remedial process label. At least a first computing device is configured to derive a remedial attribute list, wherein the remedial attribute list further comprises a plurality of remedial attribute list entries. At least a first computing device is configured to generate a plurality of treatment schemas. At least a first computing device is configured to select a treatment schema from the plurality of treatment schemas. At least a first computing device is configured to transmit the selected treatment schema to at least a second computing device.

    Autonomous cell imaging and modeling system

    公开(公告)号:US12198344B2

    公开(公告)日:2025-01-14

    申请号:US18527037

    申请日:2023-12-01

    Applicant: Insitro, Inc.

    Abstract: The present disclosure relates generally to an autonomous cell imaging and modeling platform, and more specifically to machine-learning techniques for using microscopy imaging data to continuously study live biological cells. The autonomous cell imaging and modeling platform can be applied to evaluate various cellular processes, such as cellular differentiation, optimization of cell culture (e.g., in-plate cytometry), disease modeling, histopathology imaging, and genetic and chemical screening, using a dynamic universal imaging system. In some embodiments, the platform comprises a set of label-free computational imaging techniques, self-supervised learning models, and robotic devices configured in an autonomous imaging system to study positional and morphological characteristics in particular cellular substructures of a cell culture in an efficient and non-destructive manner over time.

    BACKEND BUNDLED HEALTHCARE SERVICES PAYMENT SYSTEMS AND METHODS

    公开(公告)号:US20250005634A1

    公开(公告)日:2025-01-02

    申请号:US18406051

    申请日:2024-01-05

    Abstract: An apparatus for providing a bundled set of individually redeemable healthcare services in a purchase data record, determining a Good Faith Estimate (GFE) for the at least one healthcare service of the bundled set, associating the purchase data record with user debt for purchase of the healthcare services, providing a digital health asset token representing the purchase data record identified by and with a unique confirmation number, said purchase data record comprising the associated user debt of the at least one bundled set of healthcare services, and providing marketplace access to the token to finance the debt. The marketplace may use the token for buying, selling or trading the bundled set of healthcare services to finance the debt. The token and a Good Faith Estimate (GFE) may be provided to an Independent Dispute Resolution (IDR) process for resolving a dispute under the No Surprises Act.

    Artificial intelligence based technologies for improving patient intake

    公开(公告)号:US12183454B2

    公开(公告)日:2024-12-31

    申请号:US17940603

    申请日:2022-09-08

    Applicant: CDW LLC

    Abstract: Artificial intelligence (AI) based technologies for improving patient intake are disclosed herein. An example method includes receiving a patient intake request from a user; initiating, based on the patient intake request, a patient intake data stream including verbal responses from the user regarding patient intake of the user; applying, while simultaneously receiving the patient intake data stream, a natural language processing (NLP) model to the verbal responses from the user to output (i) textual transcriptions and (ii) intent interpretations; generating, by a care plan generation module, a recommended care plan based on the textual transcriptions and the intent interpretations; identifying, by an intent interpretation fulfillment module, one or more recipient entities to receive the textual transcriptions and the recommended care plan; and transferring the textual transcriptions and the recommended care plan to one or more recipient entity devices of the one or more recipient entities.

Patent Agency Ranking